Recombinant Cynomolgus/Rhesus SLAM/CD150 Fc Protein, CF Summary
|Cynomolgus Monkey/Rhesus Macaque SLAM/CD150|
Accession # XP_005541298.1
CF stands for Carrier Free (CF). We typically add Bovine Serum Albumin (BSA) as a carrier protein to our recombinant proteins. Adding a carrier protein enhances protein stability, increases shelf-life, and allows the recombinant protein to be stored at a more dilute concentration. The carrier free version does not contain BSA.
In general, we advise purchasing the recombinant protein with BSA for use in cell or tissue culture, or as an ELISA standard. In contrast, the carrier free protein is recommended for applications, in which the presence of BSA could interfere.
|Formulation||Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose.|
|Reconstitution||Reconstitute at 250 μg/mL in PBS.|
|Shipping||The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.|
|Stability & Storage:||Use a manual defrost freezer and avoid repeated freeze-thaw cycles.
2 μg/lane of Recombinant Cynomolgus Monkey/Rhesus Macaque SLAM/CD150 Fc Chimera Protein (Catalog # 11170-SL) was resolved with SDS-PAGE under reducing (R) and non-reducing (NR) conditions and visualized by Coomassie® Blue staining, showing bands at 60-80 kDa and 120-160 kDa, respectively.
Signaling lymphocytic activation molecule (SLAM), also known as SLAMF1 and CD150, is the founding member of the SLAM subfamily of the CD2 protein family (1, 2). SLAM is a single-pass type I membrane glycoprotein that functions as an adhesion molecule and plays an active role in the regulation of innate and adaptive immunity (1, 2, 4). Mature SLAM consists of an extracellular domain (ECD) containing an Ig-like V-type domain and an Ig-like C2-type domain, a helical transmembrane domain, and a cytoplasmic tail containing 2 immunoreceptor tyrosine-based switch motifs (ITSM) (3, 4). The ECD of cynomolgus SLAM shares 97% amino acid identity with human SLAM. In human, several isoforms resulting from alternative splicing have been identified with functional diversity (4). SLAM is expressed on T cells, B cells, thymocytes, macrophages, dendritic cells, platelets, and hematopoietic stem cells, and it is up-regulated on activated B cells and CD4+ and CD8+ T cells (4-6). SLAM interacts homophilically with low affinity, and this interaction induces a Th0/Th1 phenotype in CD8+ T cells that is characterized by clonal expansion, production of IFN-gamma, and increased cytolytic activity (7, 8). SLAM also plays a role in activation of the PI3K-Akt signaling pathway through its association with the adapter molecule SAP (9). In humans, SLAM functions as a cellular entry receptor for measles virus (10, 11). SLAM deregulation is associated with genomic complexity and independently predicts a worse outcome in chronic lymphocytic leukemia (CLL) (12).
- Yurchenko, M. et al. (2018) J. Cell. Biol. 217:1411.
- Pellegrini, J. et al. (2021) Autophagy. 17:2629.
- Wang, N. et al. (2015) Front. Immunol. 6:158.
- Gordiienko, I. (2019) Clinical Immunol. 204:14.
- Calpe, S. et al. (2008) Adv Immunol. 97:177.
- Wang, N. et al. (2004) J. Exp. Med. 199:1255.
- Mavaddat, N. et al. (2000) J. Biol. Chem. 275:28100.
- Mehrle, S. et al. (2008) Mol. Immunol. 45:796.
- Yurchenko, M.Y. et al. (2005) Exp Oncol. 27:24.
- Hsu, E.C. et al. (2001) Virology 279:9.
- Gonçalves-Carneiro, D. et al. (2017) J Virol. 91:e02255.
- Gian, M.R. et al. (2021) Br. J. Haematol. 192:1068.
No product specific FAQs exist for this product, however you mayView all Proteins and Enzyme FAQs
Reviews for Recombinant Cynomolgus/Rhesus SLAM/CD150 Fc Protein, CF
There are currently no reviews for this product. Be the first to review Recombinant Cynomolgus/Rhesus SLAM/CD150 Fc Protein, CF and earn rewards!
Have you used Recombinant Cynomolgus/Rhesus SLAM/CD150 Fc Protein, CF?
Submit a review and receive an Amazon gift card.
$25/€18/£15/$25CAN/¥75 Yuan/¥1250 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image